Overview

Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 Diabetes

Status:
Terminated
Trial end date:
2008-04-24
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe, Asia, North America and South America. The aim of this research trial is to compare the efficacy of inhaled insulin to glimepiride and metformin combination therapy in treatment of subjects with type 2 diabetes and to verify the safety of use (hypoglycaemia, pulmonary function, body weight, insulin antibodies and side effects).
Phase:
Phase 3
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Glimepiride
Insulin
Insulin, Globin Zinc
Metformin